Aller au contenu

Alex Carignan

Professeur, Faculté de médecine et des sciences de la santé
FMSS Département de microbiologie et infectiologie - Service d'infectiologie

Présentation

Sujets, disciplines ou intérêts de recherche

Épidémiologie, Maladies infectieuses, Maladie de Lyme, Anaplasmose, Maladies vectorielles, Immunisation

Adhésions

  • (2025-). Société des évaluateurs experts en sciences de la santé du Québec (SEESSQ). Montréal, Québec, Canada.
  • (2011-2022). INSPQ. Québec, Quebec, Canada.

Qualifications

  • Certificat — Maladies infectieuses. Collège des médecins du Québec. Montréal, Québec, Canada. (2012).
  • Certificat — Expertise médico-légale et médecine d'assurance (MMD6239). Université de Montréal. Montreal, Quebec, Canada. (2011).
  • Permis de spécialiste — Microbiologie médicale et infectiologie. Collège des médecins du Québec. Montréal, Québec, Canada. (2008).

Diplômes

  • MSc, Epidemiology. London School of Hygiene and Tropical Medicine. London, London, Royaume-Uni.
  • (2003-2008). Specialized medicine diploma; Medical Microbiology and Infectious Diseases. Université de Sherbrooke. Sherbrooke, QC, Canada.
  • (1998-2003). MD. Université de Montréal. Montreal, QC, Canada.

Expériences académiques

  • Professeur titulaire (Full Professor) (Département de microbiologie et d'infectiologie, Faculté de médecine et des sciences de la santé). (2020-). Université de Sherbrooke. Sherbrooke, Quebec, Canada.
  • Médecin microbiologiste-infectiologue (Service de microbiologie et maladies infectieuses). (2008-). Centre Hospitalier Universitaire de Sherbrooke. Sherbrooke, Quebec, Canada.
  • Professeur agrégé (Département de microbiologie et d'infectiologie, Faculté de médecine et des sciences de la santé). (2015-2020). Université de Sherbrooke. Sherbrooke, Quebec, Canada.
  • Professeur adjoint/Associate Professor (Microbiology and Infectious Diseases). (2011-2015). Université de Sherbrooke. Sherbrooke, QC, Canada.

Prix et distinctions

  • (2020) Mérite estrien. Journal La Tribune.
  • (2019) Chercheur de l'année (Researcher of the Year). Centre de recherche du CHUS.

Financement

  • Subvention. Prevention of Infections in Cardiac Surgery (PICS): a cluster-randomized factorial cross-over trial. Canadian Institutes of Health Research (Ottawa, Canada). 2 142 000 $. (2024-2028).
    Numéro de subvention : 202403PJT. Voir plus
  • Subvention. Prevention of Infections in Cardiac Surgery (PICS): a cluster-randomized factorial cross-over trial. Canadian Institutes of Health Research (Ottawa, Canada). 100 000 $. (2024-2025).
    Numéro de subvention : 202310PJT. Voir plus
  • Bourse. Chaire de recherche sur la maladie de Lyme et les infections émergentes. Université de Sherbrooke (QC, Canada). Chaire de recherche. 1 000 000 $. (2024-2029). Voir plus
  • Subvention. Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2). Canadian Institutes of Health Research (Ottawa, Canada). 499 936 $. (2022-2025).
    Numéro de subvention : 202207CL4. Voir plus
  • Subvention. BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections. Canadian Institutes of Health Research (Ottawa, Canada). 2 919 785 $. (2022-2025).
    Numéro de subvention : 202207CLP. Voir plus
  • Subvention. PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN). Canadian Institutes of Health Research (Ottawa, Canada). 371 024 $. (2021-2025).
    Numéro de subvention : 202104PJT. Voir plus
  • Subvention. The S. aureus Network Adaptive Platform Trial (SNAP) Canada: A Randomized Controlled Trial for Penicillin-susceptible, Methicillin-susceptible, and Methicillin-resistant Staphylococcus aureus Bloodstream Infections in Hospitalized Patients. Canadian Institutes of Health Research (Ottawa, Canada). 1 139 852 $. (2021-2025).
    Numéro de subvention : 202010PJT. Voir plus
  • Subvention. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial. Canadian Institutes of Health Research (Ottawa, Canada). 531 675 $. (2020-2022).
    Numéro de subvention : 202006PJT. Voir plus
  • Subvention. Canadian Immunization Research Network: COVID-19 Vaccine Readiness. Canadian Institutes of Health Research (Ottawa, Canada). 3 516 000 $. (2020-2022).
    Numéro de subvention : 202009CVV. Voir plus
  • Subvention. Épidémiologie classique et moléculaire des infections émergentes au Québec. Fonds de Recherche du Québec - Santé (Montreal, Canada). 60 000 $. (2018-2022).
    Numéro de subvention : 265598. Voir plus
  • Subvention. Épidémiologie classique et moléculaire des infections émergentes au Québec. Fonds de Recherche du Québec - Santé (Montreal, Canada). 145 938 $. (2018-2022).
    Numéro de subvention : 253529. Voir plus
  • Subvention. Development of serodiagnostic biomarkers for Candidemia. Canadian Institutes of Health Research (Ottawa, Canada). 100 000 $. (2016-2017).
    Numéro de subvention : 201604PJT. Voir plus
  • Subvention. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial. Canadian Institutes of Health Research (Ottawa, Canada). 2 052 576 $. (2016-2021).
    Numéro de subvention : 201603PJT. Voir plus
  • Subvention. Development of serodiagnostic biomarkers for Candidemia. Canadian Institutes of Health Research (Ottawa, Canada). 100 000 $. (2016-2017).
    Numéro de subvention : bdb8cafc4ab7d7ee0c376426b3e2f255. Voir plus
  • Subvention. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial. Canadian Institutes of Health Research (Ottawa, Canada). 743 935 $. (2016-2021).
    Numéro de subvention : 13c1a928a61bba24854d04e55bcc27a6. Voir plus
  • Subvention. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial. Canadian Institutes of Health Research (Ottawa, Canada). 402 127 $. (2016-2021).
    Numéro de subvention : 47714ddf858cf894f9ad9bfed7bde670. Voir plus
  • Subvention. Profil clinique et microbiologique des patients avec symptômes attribués à la maladie de Lyme. Fondation du Grand Montréal (Montréal, Canada). 150 000 $.

Publications

Articles

  • Smolinski, Michael, Chew, Jo Lin, Constantinescu, Cora, Buchan, C Arianne, Burton, Catherine, Carignan, Alex, Castellucci, Lana A, Suresh, Sneha, McConnell, Athena, Morris, Shaun K, Naus, Monika, Pernica, Jeffrey M, Pham-Huy, Anne, Piche-Renaud, Pierre-Philippe, Sadarangani, Manish, Top, Karina A, Cowan, Juthaporn. (2026). Hematologic adverse events following COVID-19 vaccination and revaccination in persons aged 12 and above: A Canadian Immunization Research Network study. Human vaccines & immunotherapeutics. DOI
  • Ramendra, Rayoun, Wright, Julie K, Kain, Kevin C, Kim, Bridget, Mishra, Hridesh, Zhong, Kathleen, Aslanian, Pierre, Carignan, Alex, Conly, John, Detsky, Michael, Duan, Erick, Evans, Gerald, Friedrich, Jan O, Lamontagne, Francois, Lauzier, Francois, Macfadden, Derek R, Marshall, John, McIntyre, Lauralyn, Muscedere, John, ... Daneman, Nick. (2026). Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections: A Secondary Analysis of the BALANCE Trial. JAMA network open. DOI
  • Prosty, Connor, Carignan, Alex, Chan, Adrienne K, Chen, Yan, Daley, Peter, Daneman, Nick, Kandel, Christopher, Longtin, Yves, Perez-Patrigeon, Santiago, Wuerz, Terry, Cheaveau, James, Hota, Susy S, Ogundipe, Olusola, Steiner, Theodore S, Tsang, Jennifer L Y, Archambault, Patrick, Bergevin, Marco, Brophy, James M, Girouard, Gabriel, ... McDonald, Emily G. (2026). Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trial. Trials. DOI
  • Fitzpatrick, Tiffany, Yamoah, Peter, Summerby-Murray, David, Cowan, Juthaporn, Sadarangani, Manish, Wright, Alissa, Belga, Sara, Constantinescu, Cora, Carignan, Alex, McConnell, Athena, Top, Karina A. (2025). Neurological adverse events following COVID-19 vaccination among Canadians referred to the special immunization clinic network. Vaccine. DOI
  • Lanthier, Luc, Carignan, Alex, Mutchmore, Alexandre, Plourde, Marc-Émile, Cauchon, Michel. (2025). [In hospitalized patients with bacteremia, is a 7-day antibiotic treatment noninferior to a 14-day treatment with respect to mortality?]. La Revue de medecine interne. DOI
  • Daneman, Nick, Rishu, Asgar, Pinto, Ruxandra, Rogers, Benjamin A, Shehabi, Yahya, Parke, Rachael, Cook, Deborah, Arabi, Yaseen, Muscedere, John, Reynolds, Steven, Hall, Richard, Dwivedi, Dhiraj B, McArthur, Colin, McGuinness, Shay, Yahav, Dafna, Coburn, Bryan, Geagea, Anna, Das, Pavani, Shin, Phillip, ... Fowler, Robert A. (2024). Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections. The New England journal of medicine. DOI
  • Fitzpatrick, Tiffany, Yamoah, Peter, Lacuesta, Gina, Sadarangani, Manish, Cook, Victoria, Pourshahnazari, Persia, Kalicinsky, Chrystyna, Upton, Julia E M, Cameron, Scott B, Zaborniak, Karver, Kanani, Amin, Lam, Godfrey, Burton, Catherine, Constantinescu, Cora, Pernica, Jeffrey M, Abdurrahman, Zainab, Betschel, Stephen, Drolet, Jean-Philippe, De Serres, Gaston, ... Top, Karina A. (2024). Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study. Vaccine. DOI
  • Grima, Alicia A, Kwong, Jeffrey C, Richard, Lucie, Reid, Jennifer, Raphael, Jacques, Basta, Nicole E, Carignan, Alex, Top, Karina A, Brousseau, Nicholas, Blanchette, Phillip S, Sundaram, Maria E. (2024). The safety of seasonal influenza vaccination among adults prescribed immune checkpoint inhibitors: A self-controlled case series study using administrative data. Vaccine. DOI
  • Ripoche, Marion, Irace-Cima, Alexandra, Adam-Poupart, Ariane, Baron, Geneviève, Bouchard, Catherine, Carignan, Alex, Milord, François, Ouhoummane, Najwa, Pilon, Pierre A, Thivierge, Karine, Zinszer, Kate, Chaumont, Diane. (2023). Current and future burden from Lyme disease in Québec as a result of climate change. Canada communicable disease report = Releve des maladies transmissibles au Canada. DOI
  • Carazo, Sara, Skowronski, Danuta M, Brisson, Marc, Sauvageau, Chantal, Brousseau, Nicholas, Gilca, Rodica, Ouakki, Manale, Barkati, Sapha, Fafard, Judith, Talbot, Denis, Gilca, Vladimir, Deceuninck, Geneviève, Garenc, Christophe, Carignan, Alex, De Wals, Philippe, De Serres, Gaston. (2022). Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada. JAMA network open. DOI
  • Campeau, Laurence, Roy, Valérie, Petit, Geneviève, Baron, Geneviève, Blouin, Jacinthe, Carignan, Alex. (2022). Identification of an unusual cluster of human granulocytic anaplasmosis in the Estrie region, Québec, Canada in 2021. Canada communicable disease report = Releve des maladies transmissibles au Canada. DOI
  • Pépin, Jacques, Desjardins, France, Carignan, Alex, Lambert, Michel, Vaillancourt, Isabelle, Labrie, Christiane, Mercier, Dominique, Bourque, Rachel, LeBlanc, Louiselle. (2022). Impact and benefit-cost ratio of a program for the management of latent tuberculosis infection among refugees in a region of Canada. PloS one. DOI
  • Sohani, Zahra N, Butler-Laporte, Guillaume, Aw, Andrew, Belga, Sara, Benedetti, Andrea, Carignan, Alex, Cheng, Matthew P, Coburn, Bryan, Costiniuk, Cecilia T, Ezer, Nicole, Gregson, Dan, Johnson, Andrew, Khwaja, Kosar, Lawandi, Alexander, Leung, Victor, Lother, Sylvain, MacFadden, Derek, McGuinty, Michaeline, Parkes, Leighanne, ... McDonald, Emily G. (2022). Low-dose trimethoprim-sulfamethoxazole for the treatment ofpneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial. BMJ open. DOI
  • Musonera, Jean B, Valiquette, Louis, Baron, Geneviève, Milord, François, Marcoux, Dominique, Thivierge, Karine, Bedard-Dallaire, Samuel, Pelletier, Andrée A, Lachance, Raphaël, Bourget, Jeremy, Simard, Catherine, Cantin, Emmanuelle, Abbasi, Farhad, Haraoui, Louis-Patrick, Carignan, Alex. (2022). Management and clinical outcomes of Lyme disease in acute care facilities in 2 endemic regions of Quebec, Canada: a multicentre retrospective cohort study. CMAJ open. DOI
  • Carazo, Sara, Skowronski, Danuta M, Brisson, Marc, Barkati, Sapha, Sauvageau, Chantal, Brousseau, Nicholas, Gilca, Rodica, Fafard, Judith, Talbot, Denis, Ouakki, Manale, Gilca, Vladimir, Carignan, Alex, Deceuninck, Geneviève, De Wals, Philippe, De Serres, Gaston. (2022). Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study. The Lancet. Infectious diseases. DOI
  • Carazo, Sara, Talbot, Denis, Boulianne, Nicole, Brisson, Marc, Gilca, Rodica, Deceuninck, Geneviève, Brousseau, Nicholas, Drolet, Mélanie, Ouakki, Manale, Sauvageau, Chantal, Barkati, Sapha, Fortin, Élise, Carignan, Alex, De Wals, Philippe, Skowronski, Danuta M, De Serres, Gaston. (2022). Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. DOI
  • Skowronski, Danuta M, Febriani, Yossi, Ouakki, Manale, Setayeshgar, Solmaz, El Adam, Shiraz, Zou, Macy, Talbot, Denis, Prystajecky, Natalie, Tyson, John R, Gilca, Rodica, Brousseau, Nicholas, Deceuninck, Geneviève, Galanis, Eleni, Fjell, Chris D, Sbihi, Hind, Fortin, Elise, Barkati, Sapha, Sauvageau, Chantal, Naus, Monika, ... De Serres, Gaston. (2022). Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. DOI
  • Carignan, Alex, Boudhrioua, Chiheb, Moreira, Sandrine, Pelletier, Andrée Ann, Dufour, Kevin, Pépin, Jacques, Allard, Catherine, Marcoux, Dominique, Dufresne, Philippe J. (2021). Changing Patterns of Disease Severity in Blastomyces dermatitidis Infection, Quebec, Canada. Emerging infectious diseases. DOI
  • Nadeau, Esther, Mercier, Adam, Perron, Julie, Gilbert, Mélanie, Nault, Vincent, Beaudoin, Mathieu, Abou Chakra, Claire Nour, Valiquette, Louis, Carignan, Alex. (2021). Clinical impact of accepting or rejecting a recommendation from a clinical decision support system-assisted antibiotic stewardship program. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada. DOI
  • Durand, Mathieu, Thibault, Philippe, Lévesque, Simon, Brault, Ariane, Carignan, Alex, Valiquette, Louis, Martin, Philippe, Labbé, Simon. (2021). Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its first variants in fourplex real-time quantitative reverse transcription-PCR assays. Microbial cell (Graz, Austria). DOI
  • Pépin, Jacques, Labbé, Annie-Claude, Carignan, Alex, Parent, Marie-Elise, Yu, Jennifer, Grenier, Cynthia, Beauchemin, Stéphanie, De Wals, Philippe, Valiquette, Louis, Rousseau, Marie-Claude. (2021). Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Quebec, Canada. Vaccine. DOI
  • Pépin, Jacques, De Wals, Philippe, Labbé, Annie-Claude, Carignan, Alex, Parent, Marie-Elise, Yu, Jennifer, Valiquette, Louis, Rousseau, Marie-Claude. (2021). Influenza vaccine during the 2019-2020 season and COVID-19 risk: A case-control study in Québec. Canada communicable disease report = Releve des maladies transmissibles au Canada. DOI
  • Brousseau, Nicholas, Morin, Laurianne, Ouakki, Manale, Savard, Patrice, Quach, Caroline, Longtin, Yves, Cheng, Matthew P, Carignan, Alex, Dufresne, Simon F, Leduc, Jean-Michel, Lavallée, Christian, Gauthier, Nicolas, Bestman-Smith, Julie, Arrieta, Maria-Jesus, Ishak, Magued, Lévesque, Simon, Martin, Philippe, De Serres, Gaston. (2021). SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. DOI
  • Capistran, Ève, Morin, Vincent, Marcoux, Dominique, Trudel, Esther, Gagné, Micheline, Proulx, Sandra, Nour Abou Chakra, Claire, Gagnon, Nicolas, Carignan, Alex. (2021). Validation of algorithms using International Classification of Diseases for the identification of herpes zoster episodes requiring hospitalization in Quebec, Canada. Vaccine. DOI
  • Bergevin, Marco Andres, Freppel, Wesley, Robert, Guylaine, Ambaraghassi, Georges, Aubry, Dany, Haeck, Olivier, Saint-Jean, Maude, Carignan, Alex. (2021). Validation of saliva sampling as an alternative to oro-nasopharyngeal swab for detection of SARS-CoV-2 using unextracted rRT-PCR with the Allplex 2019-nCoV assay. Journal of medical microbiology. DOI
  • Lanthier, L, Carignan, A, Plourde, M-É, Cauchon, M. (2021). [In subjects 16 years of age and older, is messenger RNA vaccine BNT162b2 against COVID-19 effective and safe?]. La Revue de medecine interne. DOI
  • Carignan, Alex, Valiquette, Louis, Grenier, Cynthia, Musonera, Jean Berchmans, Nkengurutse, Delphin, Marcil-Héguy, Anaïs, Vettese, Kim, Marcoux, Dominique, Valiquette, Corinne, Xiong, Wei Ting, Fortier, Pierre-Hughes, Généreux, Mélissa, Pépin, Jacques. (2020). Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. DOI
  • Sirard, Stéphanie, Abou Chakra, Claire Nour, Langlois, Marie-France, Perron, Julie, Carignan, Alex, Valiquette, Louis. (2020). Is Antimicrobial Dosing Adjustment Associated with Better Outcomes in Patients with Severe Obesity and Bloodstream Infections? An Exploratory Study. Antibiotics (Basel, Switzerland). DOI
  • Iorio-Morin, Christian, Hodaie, Mojgan, Sarica, Can, Dea, Nicolas, Westwick, Harrison J, Christie, Sean D, McDonald, Patrick J, Labidi, Moujahed, Farmer, Jean-Pierre, Brisebois, Simon, D'Aragon, Frédérick, Carignan, Alex, Fortin, David. (2020). Letter: The Risk of COVID-19 Infection During Neurosurgical Procedures: A Review of Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV-2) Modes of Transmission and Proposed Neurosurgery-Specific Measures for Mitigation. Neurosurgery. DOI
  • Carignan, Alex, Denis, Mélina, Abou Chakra, Claire Nour. (2020). Mortality associated with Blastomyces dermatitidis infection: A systematic review of the literature and meta-analysis. Medical mycology. DOI
  • Xiong, Wei Ting, Lévesque, Simon, Martin, Philippe, Durand, Mathieu, Lemieux, Bruno, Thibault, Philippe, Marcoux, Dominique, Gilca, Rodica, Carignan, Alex. (2020). Respiratory tract samples collected from patients in a region of Quebec, Canada, indicate the absence of early circulation of SARS-CoV-2 infection. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada. DOI
  • Carignan, Alex, Valiquette, Louis, Grenier, Cynthia, Musonera, Jean Berchmans, Nkengurutse, Delphin, Marcil-Héguy, Anaïs, Vettese, Kim, Marcoux, Dominique, Valiquette, Corinne, Xiong, Wei Ting, Fortier, Pierre-Hughes, Généreux, Mélissa, Pépin, Jacques. (2020). [Not Available]. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. DOI
  • van Oostveen, Rachel B, Romero-Palacios, Alberto, Whitlock, Richard, Lee, Shun Fu, Connolly, Stuart, Carignan, Alex, Mazer, C David, Loeb, Mark, Mertz, Dominik. (2019). Correction to: Prevention of Infections in Cardiac Surgery study (PICS): study protocol for a pragmatic cluster-randomized factorial crossover pilot trial. Trials. DOI
  • Abou Khalil, Maria, Bhatnagar, Sahir Rai, Feldman, Liane, Longtin, Yves, Vasilevsky, Carol-Ann, Carignan, Alex, Morin, Nancy, Boutros, Marylise. (2019). Development and validation of a clinical risk calculator for mortality after colectomy for fulminant Clostridium difficile colitis. The journal of trauma and acute care surgery. DOI
  • Carignan, A., Sabbagh, R., Masse, V., Gagnon, N., Montpetit, L.-P., Smith, M.-A., Raymond, M., Allard, C., Bergeron, C., Pépin, J. (2019). Effectiveness of fosfomycin tromethamine prophylaxis in preventing infection following transrectal ultrasound-guided prostate needle biopsy: Results from a large Canadian cohort. Journal of Global Antimicrobial Resistance. DOI
  • Asselin, C., Ekindi, N., Carignan, A., Richard, P.O. (2019). Gummatous penile syphilis. IDCases. DOI
  • Fakih, I., Fortin, E., Smith, M.-A., Carignan, A., Tremblay, C., Villeneuve, J., Moisan, D., Frenette, C., Quach, C., Schmidt, A.M. (2019). Healthcare-associated bloodstream infection trends under a provincial surveillance program. Infection Control and Hospital Epidemiology. DOI
  • Carignan, Alex, Valiquette, Louis, Laupland, Kevin B. (2019). Impact of climate change on emerging infectious diseases: Implications for Canada. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada. DOI
  • Daneman, N., Rishu, A.H., Pinto, R., Aslanian, P., Bagshaw, S.M., Carignan, A., Charbonney, E., Coburn, B., Cook, D.J., Detsky, M.E., Dodek, P., Hall, R., Kumar, A., Lamontagne, F., Lauzier, F., Marshall, J.C., Martin, C.M., McIntyre, L., Muscedere, J., ... Fowler, R.A. (2018). 7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: A pilot randomized clinical trial. Trials. DOI
  • Fakih, I., Fortin, E., Smith, M.-A., Carignan, A., Tremblay, C., Villeneuve, J., Moisan, D., Frenette, C., Quach, C. (2018). A ten-year review of healthcare-associated bloodstream infections from forty hospitals in Québec, Canada. Infection Control and Hospital Epidemiology. DOI
  • St-Pierre, J., Dufresne, P.J., Carignan, A., Lévesque, É., Bernard, F., Longtin, J., LeBlanc, L. (2018). Case Series: Report of the First Two Human Indigenous Cases of Cryptococcus gattii Infection in Eastern Canada. Mycopathologia. DOI
  • Carignan, A., Fortier, L.-C. (2018). Discovery of keyicin, a new antibiotic: It takes two to tango,La keyicine. Medecine/Sciences. DOI
  • Van Oostveen, R.B., Romero-Palacios, A., Whitlock, R., Lee, S.F., Connolly, S., Carignan, A., Mazer, C.D., Loeb, M., Mertz, D. (2018). Prevention of Infections in Cardiac Surgery study (PICS): Study protocol for a pragmatic cluster-randomized factorial crossover pilot trial. Trials. DOI
  • Couture-Cossette, A., Carignan, A., Mercier, A., Desruisseaux, C., Valiquette, L., Pépin, J. (2018). Secular trends in incidence of invasive betahemolytic streptococci and efficacy of adjunctive therapy in Quebec, Canada, 1996-2016. PLoS ONE. DOI
  • (2017). An outbreak of surgical site infections following craniotomy procedures associated with a change in the ultrasonic surgical aspirator decontamination process. American journal of infection control. DOI
  • (2017). Bezlotoxumab for the prevention of Clostridium difficile recurrence. Expert opinion on biological therapy. DOI
  • (2016). CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling. Molecular cancer. DOI
  • Carignan, A., Poulin, S., Martin, P., Labbé, A.-C., Valiquette, L., Al-Bachari, H., Montpetit, L.-P., Pépin, J. (2016). Efficacy of Secondary Prophylaxis with Vancomycin for Preventing Recurrent Clostridium difficile Infections. American Journal of Gastroenterology. DOI
  • Top, K.A., Billard, M.-N., Gariepy, M.-C., Rouleau, I., Pernica, J.M., Pham-Huy, A., Quach, C., Tran, D., Vaudry, W., Dobson, S., Boucher, F.D., Carignan, A., Jadavji, T., McConnell, A., McNeil, S.A., Halperin, S.A., De Serres, G. (2016). Immunizing patients with adverse events after immunization and potential contraindications to immunization: A report from the special immunization clinics network. Pediatric Infectious Disease Journal. DOI
  • Mertz, D., Whitlock, R., Kokoszka, A.Y., Smith, S.W., Carignan, A., Rehan, M., Jaffer, I.H., Alsagheir, A., Loeb, M. (2016). Routine surveillance versus independent assessment by an outcome adjudication committee in assessing patients for sternal surgical site infections after cardiac surgery. Infection Control and Hospital Epidemiology. DOI
  • Lane, D., Matte, I., Garde-Granger, P., Laplante, C., Carignan, A., Rancourt, C., Piché, A. (2015). Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers. BMC Cancer. DOI
  • Murphy, F.M., Raymond, M., Menard, P.-A., Bejar-Ardiles, K.-R., Carignan, A., Lesur, O. (2014). Ventilator associated pneumonia and endotracheal tube repositioning: An underrated risk factor. American Journal of Infection Control. DOI
  • Poulin, S., Corbeil, C., Nguyen, M., St-Denis, A., Côté, L., Le Deist, F., Carignan, A. (2013). Fatal Mycobacterium colombiense/cytomegalovirus coinfection associated with acquired immunodeficiency due to autoantibodies against interferon gamma: A case report. BMC Infectious Diseases. DOI
  • Collin, Y., Sirois, M., Carignan, A., Lawton Wackett, J.C. (2012). Group A streptococcus causing descending necrotizing mediastinitis: Report of a case and literature review. Surgical Infections. DOI
  • Carignan, A., Roussy, J.-F., Lapointe, V., Valiquette, L., Sabbagh, R., Pépin, J. (2012). Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: Time to reassess antimicrobial prophylaxis?. European Urology. DOI
  • Carignan, A., Allard, C., Pépin, J., Cossette, B., Nault, V., Valiquette, L. (2008). Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clinical Infectious Diseases. DOI
  • Allard, C., Carignan, A., Bergevin, M., Boulais, I., Tremblay, V., Robichaud, P., Duperval, R., Pepin, J. (2008). Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991-2005. Clinical Microbiology and Infection. DOI

Autres contributions

Activités professionnelles

  • Poste d'invité. Université de Sherbrooke. Titulaire — Chaire de recherche sur la maladie de Lyme et les infections émergentes. Sherbrooke, Quebec, Canada. (2024-2029).
  • Poste d'invité. Université de Sherbrooke. Titulaire — Chaire CRMUS sur la maladie de Lyme. Sherbrooke, Quebec, Canada. (2022-2024).
  • Poste d'invité. INSPQ. Membre — Comité d'évaluation de la prophylaxie post-exposition (piqûre de tique). Québec, Quebec, Canada. (2016-2017).